Axelife
Medical device maker measuring arterial stiffness for clinicians and healthcare facilities
Highlights
- New on EvolcAdded 2026-11-07
About Axelife
Axelife develops the pOpmètre®, a non-invasive medical device that measures pulse wave velocity to assess arterial stiffness and cardiovascular risk. It also calculates ankle-brachial index and central pressures.
Customers include clinics, hospitals, general practitioners, specialist physicians and multidisciplinary health centres. The company is based in Paris and was founded in 2010.
Product: The pOpmètre® medical device measures pulse wave velocity to assess arterial stiffness and cardiovascular risk.
Jobs at Axelife
More health & medtech companies
Axiwa
Medical equipment sales and biomedical maintenance for organizations preparing for influenza risksNew on EvolcAxomove
Digital physical therapy and workplace injury-prevention programs for healthcare providers, employers, insurers and patientsNew on EvolcAxorus
Develops a non-invasive photoacoustic contact lens for people with retinal blindness, including dry AMD and retinitis pigmentosaNew on EvolcAzergo
Ergonomic workplace equipment and personalised workstation adaptations for employers and workersNew on EvolcAzmed
AI software for medical imaging that helps healthcare teams detect and triage findings in X-rays and CT scansNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Hosting
- VercelHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-vercel-id
- Response headerx-vercel-id
- Response headerx-vercel-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.